ACLY Antikörper (pSer455)
Kurzübersicht für ACLY Antikörper (pSer455) (ABIN6136002)
Target
Alle ACLY Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer455
-
Sequenz
- TASFS
-
Kreuzreaktivität
- Maus, Ratte
-
Produktmerkmale
- Phosphorylated Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthetic phosphorylated peptide around S455 of human ACLY (NP_001087.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IHC,1:50 - 1:100,IP,1:50 - 1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Andere Bezeichnung
- ACLY
-
Hintergrund
- ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine. Multiple transcript variants encoding distinct isoforms have been identified for this gene.,ACLY,ACL,ATPCL,CLATP,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Insulin Receptor Signaling Pathway,Warburg Effect,Protein phosphorylation,ACLY
-
Molekulargewicht
- 91 kDa/119 kDa/120 kDa
-
Gen-ID
- 47
-
UniProt
- P53396
-
Pathways
- Warburg Effekt
Target
-